BATS BZX Real-Time Price
As of 3:22pm ET
| -0.045 / -1.81%|
The 6 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 3.75, with a high estimate of 6.00 and a low estimate of 2.00. The median estimate represents a +54.00% increase from the last price of 2.44.
The current consensus among 9 polled investment analysts is to Hold stock in ImmunoGen Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.